Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/24/2012CN102753544A 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/24/2012CN102753543A A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
10/24/2012CN102753542A Substituted benzoazepines as toll-like receptor modulators
10/24/2012CN102753541A Carboxamide compounds and their use as calpain inhibitors iv
10/24/2012CN102753540A A4ss2 neuronal nicotinic acetylcholine receptor ligands
10/24/2012CN102753539A Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012CN102753538A Sultam derivatives
10/24/2012CN102753535A Quinazolines as potassium ion channel inhibitors
10/24/2012CN102753533A Imidazolidinedione derivatives
10/24/2012CN102753530A Benzazepine compound
10/24/2012CN102753528A Diphenyl azepine derivatives as monoamine reuptake inhibitors
10/24/2012CN102753526A Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications
10/24/2012CN102753522A Substituted pyrrolidine-2-carboxamides
10/24/2012CN102753521A Anti-leishmania compound and anti-leishmania drug
10/24/2012CN102753520A N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
10/24/2012CN102753519A Bis-acylated hydroxylamine derivatives
10/24/2012CN102753187A Peptide dicer substrate agents and methods for their specific inhibition of gene expression
10/24/2012CN102753186A Modulation of angiopoietin-like 3 expression
10/24/2012CN102753184A Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
10/24/2012CN102753183A Agent for improving motility function
10/24/2012CN102753182A Concentrated therapeutic phospholipid compositions
10/24/2012CN102753181A A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
10/24/2012CN102753180A Nestorone tm /estradiol transdermal gel
10/24/2012CN102753179A 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/24/2012CN102753178A Piroxicam-containing endermic preparation
10/24/2012CN102753177A Heat shock protein binding compounds, compositions, and methods for making and using same
10/24/2012CN102753176A Therapeutic combination comprising a cdc7 inhibitor and an antineoplastic agent
10/24/2012CN102753175A Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same
10/24/2012CN102753174A Drug combination with theobromine and its use in therapy
10/24/2012CN102753173A Hcv combination therapy
10/24/2012CN102753172A 5-HT4 receptor agonists for the treatment of dementia
10/24/2012CN102753171A Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/24/2012CN102753170A Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
10/24/2012CN102753169A Topical transdermal dexmedetomidine compositions and methods of use thereof
10/24/2012CN102753168A Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
10/24/2012CN102753167A New benzathine salts of ace inhibitors, process for their preparation and their use for the treatment of cardiovascular diseases
10/24/2012CN102753165A Composition including naphthoquinone compound for treating and preventing hearing loss
10/24/2012CN102753164A Cancer stem cell-targeted and drug resistant cancer therapy
10/24/2012CN102753163A Composition comprising as active ingredient l-carnitine in combination with hydroxykynurenine-o-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
10/24/2012CN102753162A Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
10/24/2012CN102753161A Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
10/24/2012CN102753160A Polymeric or oligomeric active ingredients having a biocidal effect, method for the production thereof, and composition comprising a polymeric or oligomeric active ingredient
10/24/2012CN102753159A Pharmaceutical composition comprising propofol
10/24/2012CN102753158A Transdermally absorbed preparation of anti-dementia drug
10/24/2012CN102753157A Low toxicity topical active agent delivery system
10/24/2012CN102753155A 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
10/24/2012CN102753154A 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts
10/24/2012CN102753145A Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom
10/24/2012CN102753144A Treatment for inflammatory bowel disease
10/24/2012CN102753142A Suppository for rectal, vaginal or urethral administration containing a probiotic, an antibiotic and an unsaturated non- esterified fatty acid
10/24/2012CN102753022A Selective heterocyclic sphingosine 1 phosphate receptor modulators
10/24/2012CN102753019A Compounds for the treatment of neurologic disorders
10/24/2012CN102746995A Preparation method for isochromophilone VIII and application of same in preparation of antineoplastic drugs
10/24/2012CN102746363A High purity aescine B bulk drug, its preparation method and medical application
10/24/2012CN102746360A Synthesis and application of four new conjugates of camptothecin-steroid
10/24/2012CN102746353A Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
10/24/2012CN102746337A 2,4-pyrimidinediamine compound and preparation method thereof
10/24/2012CN102746336A Phosphoramidate alkylator prodrugs
10/24/2012CN102746326A P-nitro-cinnamic acid metal complex and preparation method and application thereof
10/24/2012CN102746325A Compound 1,10-N-decylene lycorine dibromo salt, pharmaceutical composition and application thereof in medicine
10/24/2012CN102746324A Purification method of cefotiam hydrochloride and aseptic powder injection of cefotiam hydrochloride
10/24/2012CN102746314A Stable 7-membered lactonic ring-containing camptothecin compound and its preparation method and use
10/24/2012CN102746309A 1-N-ethyl-4-N-2'-substituted acylhydrazine-1H-pyrazol [3, 4-d] miazines derivative as well as preparation method and application thereof
10/24/2012CN102746308A Allopurinol derivative and preparation method and application thereof
10/24/2012CN102746307A 1-N-benzyl allopurinol derivative as well as preparation method and application thereof
10/24/2012CN102746306A Allopurinol derivative and preparation method and application thereof
10/24/2012CN102746304A Purinamine compound and preparation method thereof
10/24/2012CN102746301A 8-phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
10/24/2012CN102746300A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
10/24/2012CN102746299A 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
10/24/2012CN102746298A Pyridopyrimidinone inhibitors of Pl3K[alpha]
10/24/2012CN102746297A Oxazolidinone antibiotics
10/24/2012CN102746296A Oxazolidinone antibiotics
10/24/2012CN102746292A Cyclized berberine derivatives, preparation method and uses thereof
10/24/2012CN102746291A 13-substituted berberine derivatives and preparation method thereof, and uses of 13-substituted berberine derivatives as anti-tuberculosis drugs
10/24/2012CN102746290A Thiazole compound and preparation method thereof
10/24/2012CN102746287A Oxazolidinone compound and preparation method thereof
10/24/2012CN102746285A Compounds and compositions as HEDGEHOG pathway modulators
10/24/2012CN102746281A 4-1,2,3-triazole-coumarin derivative and its preparation method and application
10/24/2012CN102746280A Pyrimidone compound and preparation method thereof
10/24/2012CN102746278A Chiral pseudonucleoside compound and its preparation method and use
10/24/2012CN102746273A Esomeprazole sodium polymorph and application of esomeprazole sodium polymorph in drugs for injection
10/24/2012CN102746272A Esomeprazole sodium polymorph, preparation method and application thereof
10/24/2012CN102746264A 7-benzyloxy hesperetin, preparation method and application thereof
10/24/2012CN102746259A Labdane diterpenoid compounds, arborvitae seed extract, preparation method thereof and application thereof
10/24/2012CN102746255A Compound having anti-tumor activity, and preparation method and application thereof
10/24/2012CN102746241A 2, 3, 5-trisubstituted benzamide compound, and preparation method and application thereof
10/24/2012CN102746240A Anti-infective pyrimidines and uses thereof
10/24/2012CN102746239A Uracil or thymine derivative for treating hepatitis c
10/24/2012CN102746234A Process for the sulfinylation of a pyrazole derivative
10/24/2012CN102746233A Process for the sulfinylation of a pyrazole derivative
10/24/2012CN102746227A Dimemorfan phosphate crystal form II and preparation method thereof, and pharmaceutical composition
10/24/2012CN102746226A Acridine derivative and preparation method and application thereof
10/24/2012CN102746220A Novel pyridine alkaloids, preparation process thereof, and the uses of the pyridine alkaloids
10/24/2012CN102746214A Novel indoline compounds
10/24/2012CN102746213A Cinnamamide histone deacetylase inhibitor, preparation method thereof, and application thereof
10/24/2012CN102746212A Beta-elemene indole derivative, preparation and application thereof
10/24/2012CN102746183A Tigecycline crystalline hydrate, preparation method thereof and uses thereof
10/24/2012CN102746181A 4-methoxy-N,N'-disubstituted phenyl-1,3-benzene diamide compounds and application thereof
10/24/2012CN102746159A 4-methoxy-1,3-phthalic diester derivative, and preparation and application thereof
1 ... 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 ... 7860